Tap the topic of interest to collapse the information.
Cannabinoids in Treating Fibromyalgia, Rheumatoid Arthritis, and Osteoarthritis (California REsidents)
Exclusive Research Opportunity For California Residents We are excited to share a new research opportunity with you! Researchers from the University of Michigan are conducting a study on the efficacy of different cannabinoids in treating Fibromyalgia, Rheumatoid Arthritis, and Osteoarthritis and YOU have the opportunity to participate! If you complete the study you may receive up to $500 in Amazon gift cards. Learn more here! The study sponsors are LEVEL and Overcome. Participants will receive a study product in the form of a tablet or capsule from one of the sponsors. Each participant will be in the study for 12 weeks and able to do so from the comfort and safety of their home via their smartphone. The study is limited and on a first come first serve basis. To learn more and find out if you are eligible to participate, please visit releaf.at/umpain
Patients with dermatomyositis are invited to join a study opportunity to help advance research! If you are aged 18+ with dermatomyositis and you do not have chronic kidney disease, you could be part of the work that may help researchers understand more about the disease, and how to possibly treat it. Check your eligibility below...
Prescription Opioid Taper Support (POTS) and Medical Cannabis Study
Conducted By: Massachusetts General Hospital, Cambridge Health Alliance, MaineHealth Location: At-home or in-person at one of three study sites in Massachusetts and Maine Description: The POTS Study is investigating how medical cannabis and a six-month pain management training program can affect opioid use and pain. The goal of the study is to see whether medical cannabis and/or the pain management program might help people reduce their dose of opioid medications and better manage their pain. The study will involve 3 components:
A weekly Prescription Opioid Taper Support (POTS) group, where you will work with trained clinicians to learn pain management skills and create an individualized opioid reduction plan to match your goals. Groups meet weekly for 26 weeks over Zoom.
Daily surveys, where you will be asked to complete a short (1-2 minute) survey on your phone each day to help keep track of your pain levels, medications, and health.
8 study visits, which are completed over 6 months, and can be done in person or via Zoom. Day and evening appointments are available.
You can earn up to $1,130 for your participation. Medical cannabis and medical cannabis certificates will not be provided directly by this research study. Who can participate: Adults ages 18-75 who use prescription opioid medications for chronic pain and do not regularly use cannabis Contact: Call 617-643-4537 or email firstname.lastname@example.org
Treatment of Worry and Anxiety in those with Pain
Conducted By: Boston University Location: Home-Based Description: This study is completely online and via mobile device and will last 10-weeks. All participants will receive a digital (online) treatment for anxiety and worry either at the beginning or end of the 10-week period. The study will also involve completing questionnaires on 4 occasions and completing 3 phone calls. Participants can be compensated up to $90 in Amazon giftcards for their time. Who Can Participate: The study is for adults living in the United States who have persistent muscle or joint pain(>3 months) and have problems with anxiety.
Study Website: sites.bu.edu/painstudy This study has been approved by Boston University-CRC IRB (protocol number 5975E). The registered clinical trial ID is NCT04907656.
New Non-Opioid Treatment for Chronic Pain
Conducted By: NIH and FDA Location: Multiple Sites Around the U.S. (Visit Link for more information). Description: A unique new program to bring new non-opioid treatments to chronic pain patients. This is an Early Phase Pain Investigation Clinical Network (EPPIC-Net) Study.
Study Option 1 The primary objective of this study is to evaluate the safety and efficacy of two doses of CNTX-6970 for the treatment of pain related to OA of the knee compared to placebo. CNTX-6970 is being developed as a new treatment for chronic pain, including painful osteoarthritis of the knee.
Study Option 2 The SKOAP Study is a Sequenced strategy for improving outcomes in people with Knee OsteoArthritis Pain (SKOAP). It is a national study, funded by the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®. SKOAP compares non-opioid pain treatments with the goal of reducing KOA pain and improving function to find out what treatments work best for which patients.
Conducted By: California State University, Fresno (CSUF) Location: Online Survey Description: My name is Thalia Valdez, I’m a Physical Therapy graduate student at California State University, Fresno (CSUF). Under the guidance of Dr. Caio Sarmento, we are conducting a survey on the perceived effectiveness and satisfaction with commonly prescribed treatments for the management of fibromyalgia symptoms. This is an anonymous survey for those 18 and older diagnosed with Fibromyalgia. It will take about 15 minutes to complete. Please follow the link below for more details, and to take the survey. Thank you for your consideration! Who Can Participate: Those 18 and older diagnosed with Fibromyalgia Contact: 559-278-2065